PROFILE

SASE Kazuhiro, M.D., Ph.D.


Department of Clinical Pharmacology

Short Biography

1980-1986
M.D. Kyoto University School of Medicine
1987-1989
Residency, Internal Medicine & Anesthesiology, Kitano Hospital
1989-1993
Ph.D. Kyoto University Graduate School of Medicine
1994-1997
Research Fellow, Cardiovascular Division , Brigham and Women’s Hospital, Harvard Medical School, USA
1997-1998
Senior Cardiologist, Shimabara Hospital
1998
Planning Division / ER, National Cardiovascular Center
1999-2000
Senior Medical Reviewer, Pharmaceuticals and Medical Devices Evaluation Center, Ministry of Health, Labour and Welfare
2001-2005
Director of Clinical Research Unit, National Cardiovascular Center
2005-
Professor, Clinical Pharmacology, Juntendo University
 

Keywords

  • Regulatory Science
  • Clinical Pharmacology
  • Clinical Evaluation of Medical Devices
  • Global Regulatory Harmonization
  • Cardio-oncology

Main Research Topics and Interests

  • International Consortium for Cardiovascular Registries (ICCR)
  • US-Japan Harmonization by Doing (HBD)
  • Japanese Registry for Mechanically Assisted Circulatory Support (J-MACS)
  • Distributed Data Model and Unique Device Identifier (UDI)
  • In Vitro Diagnostics and Molecular Biomarkers for Precision Medicine

Publications (in English)

  • Original Articles (25) <Total Impact Factor: 100.1, Citations: 1,245, Citation Index: 49.8>>
  • Review Articles (2) <Total Impact Factor: 3.6, Citations: 70, Citation Index: 35.0>>
  • Books (3)

Recent Main Publications

  • Kataoka Y, Yasuda S, Miyamoto Y, et al: Clinical Predictors of Atheroma Progression Despite Optimal Glycemic Control in Early-Stage Diabetic Patients with Coronary Artery Disease: Insight from the DIANA Study. J Atheroscler Thromb, 2014; 21; 509-518.
  • Kamide K, Asayama K, Katsuya T, et al: Genome-wide Response to Antihypertensive Medication Using Home Blood Pressure Measurements: A Pilot Study Nested within the HOMED-BP Study. Pharmacogenomics, 2013; 14; 1709-1721.
  • Kataoka Y, Yasuda S, Miyamoto Y, et al: Effects of Voglibose and Nateglinide on Glycemic Status and Coronary Atherosclerosis in Early-Stage Diabetic Patients. Circ J, 2012; 76; 712-720.
  • More

Other Specific Comments

Global Regulatory Harmonization and Related Activities

2005-
Steering Committee, US-Japan Harmonization by Doing (HBD).
2005-2012
Study Group 5 (Clinical Evaluation), Global Harmonization Task Force (GHTF).
2006-2013
Co-chair, Working Group 2 (Post-Markting Registry of Medical Devices). US-Japan Harmonization by Doing (HBD)

Japanese Government/Academic Committee Responsibilities

2001-2003
Project member, Translational Research Informatics Center. City of Kobe
2003-2005
Technical Advisory Committee, Japanese Medical Association Center for Clinical Trials (JMACCT)
2005-2005
Working Group, High-Speed IP Handover for Mobile Telemedicine to Support Pre-Hospital Care and Emergency Medicine. Kinki Bureau of Telecommunications. Ministry of Internal Affairs and Communications
2005-2006
Senior Research Fellow (Imura-Group/Proposal for National Policy on Clinical Research), Center for Research and Development Strategy, Japan Science and Technology Agency (CRDS/JST)
2006-2007
Group on Implantable Mechanically Assisted Circulatory Support. Committee for Evaluation of Next-Generation Medical Devices, National Institute for Health Sciences, Ministry of Health, Labour, and Welfare
2006-
External Advisory Board Member, Pharmaceuticals and Medical Devices Agency (PMDA)
2007-
Operational Committee, Japanese Registry for Mechanically Assisted Circulatory Support (J-MACS). Pharmaceuticals and Medical Devices Agency (PMDA)
2007-
Steering Committee, Japanese Regisry for Mechanically Assisted Circulatory Support (J-MACS), Pharmaceuticals and Medical Devices Agency (PMDA)
2008-
Senior Member, Division of Regulatory Sciences, The Pharmaceutical Society of Japan
2009-2009
Advisory Board to the Committee on Health Research Initiatives, Cabinet Office
2012-
Reviewer. Program to Develop Medical Equipment and Devices to Solve Unmet Medical Needs, Ministry of Economy, Trade and Industry

Link

Department of Clinical Pharmacology